Jimena Labbe
Industry Report: Generic
Pharmaceutical Manufacturing in the US
The
Pharmaceutical Industry focuses on developing drug for human and no-human
subjects.
I
found it very interesting that the major demand industries are not only
pharmacies and drug stores, but Cosmetic and Toiletry wholesaling as well.
Moreover, further down the report, there is mention to the major products and
services in the pharmaceutical industry are:
- · Preparations for metabolic drugs and
- · Preparations for cardiovascular drugs.
- · Preparations for psychotherapeutic drugs
I
found this very surprising; it is a direct result of the overweight issues the
USA is faced with today, as well as the increase in depression diagnosis.
The
US is considered to be a mixed economy. This occurs because the government
takes charge of certain aspects, like Medicaid, but still leaves space for a
free market. It would be interesting to analyze exactly how profitable this
industry is and how much it contributes to the GDP.
Although
I think the industry will not go extinct anytime in the foreseeable future
(because we need medicine) I would
like to understand if the future of the industry depends strictly on advances
and discoveries that occur in the medical field.
Novo
Nordisk is my assigned company. Their net profit reached $1.7 billion and shares were at $3.14 during the first half of 2012 because of different sales of insulin drugs like Victoza and Levemir (NJ.com). Unfortunately, their shares dropped last Monday
after U.S Regulators asked for more information about a new insulin drug before deciding if the drug can put it on the market (The New
York Times). It will be interesting to see how this pans out.
References
Press,
The Associated. "Novo Nordisk Shares Fall After Delay in Approval." The New York Times. The New York Times, 12
Feb. 2013. Web. 13 Feb. 2013.
http://www.nj.com/business/index.ssf/2012/08/novo_nordisk_reports_higher_sa.html
http://www.nj.com/business/index.ssf/2012/08/novo_nordisk_reports_higher_sa.html
Industry Report:
http://clients1.ibisworld.com.proxyau.wrlc.org/reports/us/industry/default.aspx?entid=488
Hi Jimena,
ReplyDeleteGood first blog post! It's good that you found the other aspects of the pharmaceutical industry that may not be as prevalent in our minds. This will help your team in the final presentation. For future blog posts, make sure you have at least 300 words, excluding the questions. Also, make the blog post more cohesive, which will be easier as the blogs from now on will only have one question to answer. I also want to see more analysis in the future posts. For example, do you think the pharmaceutical company would be better/more profitable/innovative in a different kind of economy, ie: monopolistic? Why or why not?